Genzyme update on supply of Thyrogen® (thyrotropin alfa for injection)

September 12, 2011 Genzyme would like to provide an update on Thyrogen availability. Intermittent shipments of the product have resumed globally with the expectation that current supply projections for the remainder of 2011 will meet approximately 40 to 60 percent of global demand for Thyrogen. Genzyme continues to advise health care providers not to schedule any new Thyrogen treatments until they have secured product.
More

AACE
Guidelines

AACE Clinical Practice Guidelines are systematically developed, evidence-based documents that assist practitioners about appropriate health care decisions

AACE Position Statements

AACE's Position Statements meet rigorous criteria before being published and utilized and serve as one of the worlds' most trusted sources

AACE
Publications

AACE continually strives to bring to the world definitive protocols, guidelines and discoveries which further and enhance the greater medical health of the general public.

Find an Endocrinologist

Find an Endocrinologist in your area by entering a ZIP code, or your city and state using our search feature.